In a study conducted on TIL of DLBCL, LAG‐3 showed higher expression in CD4‐positive regulatory T‐cells (Treg) and CD8‐positive T cells than in CD4‐positive non‐Tregs.27 The gene discussed is CD8A; the disease is diffuse large B-cell lymphoma.